The Critical Role of the Variable Domain in Driving Proteotoxicity and Aggregation in Full-length Light Chains
Sarita Puri, Angela Gadda, Ivan Polsinelli, Maria Monica Barzago, Angelo Toto, Manoj Kumar Sriramoju, Cristina Visentin, Luca Broggini, Diane Marie Valérie Bonnet, Rosaria Russo, Antonio Chaves-Sanjuán, Giampaolo Merlini, Mario Nuvolone, Giovanni Palladini, Stefano Gianni, Shang‐Te Danny Hsu, Luisa Diomede, Stéfano Ricagno
Abstract
• CL domain stabilizes the VL domain and full-length AL55. • The crystal structure of AL55 reveals a non-canonical open conformation. • Non-native interactions between VL domains of adjacent dimers are formed in the crystals. • Full-length AL55 dimers are the most cardiotoxic species. • In vitro aggregation of VL domains does not recapitulate in vivo fibril morphology. Light chain (AL) amyloidosis is the most common systemic amyloid disease characterized by abnormal accumulation of amyloid fibrils derived from immunoglobulin light chains (LCs). Both full-length (FL) LCs and their isolated variable (VL) and constant (CL) domains contribute to amyloid deposits in multiple organs, with the VL domain predominantly forming the fibril core. However, the role and interplay of these domains in amyloid aggregation and toxicity are poorly understood. Characterizing the amyloidogenic λ6-LC AL55, this study explores the properties of both FL and isolated domains and compares them with the available patient-derived data. FL AL55 biophysical features result from the interplay between its VL and CL domains where the limited VL-CL interface might play a major role. Slow refolding kinetic of FL confirms the unfolded VL domain as a kinetic trap possibly shifting the process towards misfolding. The X-ray structure of FL AL55 shows that VL domains may detach from the native dimeric assembly and establish non-native interdimeric interfaces. Additionally, isolated VL domains display significantly lower soluble toxicity compared to FL and do not form fibrils similar to those found ex vivo . Thus the data obtained in this work allowed us to draw a molecular sketch of the aggregation pathway for amyloidogenic LCs.